Agilent Technologies Inc.A
The next Agilent Technologies Inc. dividend went ex 15 days ago for 18c and will be paid in 8 days.
The previous Agilent Technologies Inc. dividend was 18c and it went ex 4 months ago and it was paid 3 months ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 4.7.
|Summary||Previous dividend||Next dividend|
|Declaration date||20 May 2020 (Wed)||16 Sep 2020 (Wed)|
|Ex-div date||29 Jun 2020 (Mon)||05 Oct 2020 (Mon)|
|Pay date||22 Jul 2020 (Wed)||28 Oct 2020 (Wed)|
Enter the number of Agilent Technologies Inc. shares you hold and we'll calculate your dividend payments:
Sign up for Agilent Technologies Inc. and we'll email your payment info when their dividends are declared.
Add Agilent Technologies Inc. to receive free notifications when they declare their dividends.
Your account is set up to receive Agilent Technologies Inc. notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Quarterly||13 Nov 2024||23 Dec 2024||22 Jan 2025||USD||Sign up||—|
|Forecast||Quarterly||18 Sep 2024||30 Sep 2024||22 Oct 2024||USD||Sign up||—|
|Forecast||Quarterly||22 May 2024||01 Jul 2024||24 Jul 2024||USD||Sign up||—|
|Forecast||Quarterly||20 Mar 2024||01 Apr 2024||24 Apr 2024||USD||Sign up||—|
|Forecast||Quarterly||15 Nov 2023||22 Dec 2023||24 Jan 2024||USD||Sign up||—|
|Forecast||Quarterly||20 Sep 2023||02 Oct 2023||25 Oct 2023||USD||Sign up||—|
|Forecast||Quarterly||17 May 2023||30 Jun 2023||26 Jul 2023||USD||Sign up||—|
|Forecast||Quarterly||15 Mar 2023||03 Apr 2023||26 Apr 2023||USD||Sign up||—|
|Forecast||Quarterly||16 Nov 2022||23 Dec 2022||25 Jan 2023||USD||Sign up||—|
|Forecast||Quarterly||21 Sep 2022||03 Oct 2022||26 Oct 2022||USD||Sign up||—|
|Forecast||Quarterly||18 May 2022||01 Jul 2022||27 Jul 2022||USD||Sign up||—|
|Forecast||Quarterly||16 Mar 2022||04 Apr 2022||27 Apr 2022||USD||Sign up||—|
|Forecast||Quarterly||17 Nov 2021||27 Dec 2021||26 Jan 2022||USD||Sign up||—|
|Forecast||Quarterly||15 Sep 2021||04 Oct 2021||27 Oct 2021||USD||Sign up||—|
|Forecast||Quarterly||19 May 2021||28 Jun 2021||21 Jul 2021||USD||Sign up||—|
|Forecast||Quarterly||17 Mar 2021||29 Mar 2021||21 Apr 2021||USD||Sign up||—|
|Forecast||Quarterly||18 Nov 2020||28 Dec 2020||27 Jan 2021||USD||Sign up||—|
|Declared||Quarterly||16 Sep 2020||05 Oct 2020||28 Oct 2020||USD||18c||18c||😄|
|Paid||Quarterly||20 May 2020||29 Jun 2020||22 Jul 2020||USD||18c||18c||😄|
|Paid||Quarterly||18 Mar 2020||30 Mar 2020||22 Apr 2020||USD||18c||18c||😄|
|Paid||Quarterly||20 Nov 2019||30 Dec 2019||22 Jan 2020||USD||18.1c||18c||😄|
|Paid||Quarterly||18 Sep 2019||30 Sep 2019||23 Oct 2019||USD||16.4c||16.4c||😄|
|Paid||Quarterly||22 May 2019||01 Jul 2019||24 Jul 2019||USD||—||16.4c|
|Paid||Quarterly||20 Mar 2019||01 Apr 2019||24 Apr 2019||USD||—||16.4c|
|Paid||Quarterly||14 Nov 2018||28 Dec 2018||23 Jan 2019||USD||—||16.4c|
|Paid||Quarterly||19 Sep 2018||01 Oct 2018||24 Oct 2018||USD||—||14.9c|
|Paid||Quarterly||16 May 2018||02 Jul 2018||25 Jul 2018||USD||—||14.9c|
|Paid||Quarterly||21 Mar 2018||02 Apr 2018||25 Apr 2018||USD||—||14.9c|
|Paid||Quarterly||15 Nov 2017||29 Dec 2017||24 Jan 2018||USD||—||14.9c|
|Paid||Quarterly||20 Sep 2017||02 Oct 2017||25 Oct 2017||USD||—||13.2c|
|Paid||Quarterly||17 May 2017||29 Jun 2017||26 Jul 2017||USD||—||13.2c|
|Paid||Quarterly||15 Mar 2017||31 Mar 2017||26 Apr 2017||USD||—||13.2c|
|Paid||Quarterly||17 Nov 2016||29 Dec 2016||25 Jan 2017||USD||—||13.2c|
|Paid||Quarterly||21 Sep 2016||30 Sep 2016||26 Oct 2016||USD||—||11.5c|
|Paid||Quarterly||18 May 2016||30 Jun 2016||27 Jul 2016||USD||—||11.5c|
|Paid||Quarterly||16 Mar 2016||01 Apr 2016||27 Apr 2016||USD||—||11.5c|
|Paid||Quarterly||19 Nov 2015||31 Dec 2015||27 Jan 2016||USD||—||11.5c|
|Paid||Quarterly||16 Sep 2015||25 Sep 2015||21 Oct 2015||USD||—||10c|
|Paid||Quarterly||20 May 2015||26 Jun 2015||22 Jul 2015||USD||—||10c|
|Paid||Quarterly||18 Mar 2015||27 Mar 2015||22 Apr 2015||USD||—||10c|
|Paid||Quarterly||20 Nov 2014||02 Jan 2015||28 Jan 2015||USD||—||10c|
|Paid||Quarterly||17 Sep 2014||26 Sep 2014||22 Oct 2014||USD||—||13.2c|
|Paid||Quarterly||22 May 2014||27 Jun 2014||23 Jul 2014||USD||—||13.2c|
|Paid||Quarterly||01 Apr 2014||09 Apr 2014||23 Apr 2014||USD||—||13.2c|
|Paid||Quarterly||22 Nov 2013||27 Dec 2013||22 Jan 2014||USD||—||13.2c|
|Paid||Quarterly||18 Sep 2013||27 Sep 2013||23 Oct 2013||USD||—||12c|
|Paid||Quarterly||23 May 2013||28 Jun 2013||24 Jul 2013||USD||—||12c|
|Paid||Quarterly||17 Jan 2013||28 Mar 2013||24 Apr 2013||USD||—||12c|
|Paid||Quarterly||16 Nov 2012||27 Dec 2012||23 Jan 2013||USD||—||10c|
|Paid||Quarterly||–||28 Sep 2012||24 Oct 2012||USD||—||10c|
|Paid||Quarterly||–||29 Jun 2012||25 Jul 2012||USD||—||10c|
|Paid||Quarterly||–||30 Mar 2012||25 Apr 2012||USD||—||10c|
|2020||Sign Up Required|
|2021||Sign Up Required|
|2022||Sign Up Required|
|2023||Sign Up Required|
|2024||Sign Up Required|
Agilent Technologies Inc. Optimized Dividend Chart
About Agilent Technologies Inc.
Agilent Technologies, Inc., incorporated on May 4, 1999, provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment brings together the Company's analytical laboratory instrumentation and informatics. The Company's diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
The Company’s next-generation sequencing (NGS) library prep solution is Agilent SureSelect, which is a target enrichment research solution that provides total workflow management for laboratories, from QC to target enrichment, to analysis and interpretation. SureSelect is a streamlined, high-sensitivity (HS) solution for research, optimized for labs with a requirement to sequence DNA from formalin-fixed paraffin-embedded (FFPE) samples.
Life Sciences and Applied Markets Business segment
The Company's life sciences and applied markets business segment provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its product categories include liquid chromatography (LC) systems and components; liquid chromatography mass spectrometry (LCMS) systems; gas chromatography (GC) systems and components; gas chromatography mass spectrometry (GCMS) systems; inductively coupled plasma mass spectrometry (ICP-MS) instruments; atomic absorption (AA) instruments; microwave plasma-atomic emission spectrometry (MP-AES) instruments; inductively coupled plasma optical emission spectrometry (ICP-OES) instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing, and vacuum pumps and measurement technologies.
Diagnostics and Genomics Business segment
The Company's diagnostics and genomics business segment consists of approximately three areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its pathology solutions business is focused on product offerings to cancer diagnostics and anatomic pathology workflows. The portfolio of offerings includes immunohistochemistry (IHC), In Situ Hybridization (ISH), Hematoxylin and Eosin (H&E), staining and special staining. Its genomics business includes arrays for deoxyribonucleic acid (DNA) mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as Next Generation Sequencing (NGS) target enrichment. Its nucleic acid solutions business provides equipment and capability focused on production of synthesized oligonucleotides under pharmaceutical Good Manufacturing Practices (GMP) conditions for use as active pharmaceutical ingredients (API) in a class of drugs that utilize nucleic acid molecules for disease therapy.
Agilent CrossLab Business segment
The Agilent CrossLab business segment's majority of the portfolio is vendor neutral, which means the Company can serve and supply customers regardless of their instrument purchase choices. Its solutions range from chemistries and supplies to services and software helping to connect the entire lab. Its product categories in consumables include GC and LC columns, sample preparation products, custom chemistries and a selection of laboratory instrument supplies. Its services include startup, operational, training and compliance support, as well as asset management and consultative services that rise customer productivity.
- United States
- Share Price
- $105.49 (yesterday's closing price)
- Shares in Issue
- 316 million
- Market Cap
- Market Indices
- S&P 500